世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000043025

2025〜2030年のドイツの分子診断市場 - 2025年におけるサプライヤーシェア、国別の分析装置導入台数と戦略、2025〜2030年における感染症、遺伝子、がん、法医学、親子鑑定検査における数量と販売セグメント予測

VPGMarketResearch

2025-2030 Germany Molecular Diagnostics Market: 2025 Supplier Shares, Analyzer Installed Base and Strategies, 2025-2030 Volume and Sales Segment Forecasts for Individual Infectious, Genetic, Cancer, Forensic and Paternity Tests

発刊日 2025/11/15

言語英語

体裁PDF

ライセンス/価格

0000043025

Local PDF
Global PDF

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。電子媒体での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

LeadingMarketResearch.com のこのデータベースは、感染症、遺伝性疾患、がん診断、法医学および親子鑑定アプリケーションに関する2024年のサプライヤーシェア、2024 〜 2028年の数量と売上予測、および主要な検査用の新技術や製品を開発または販売している企業の包括的なリストを提供します。

主要企業

  • Abbott
  • Agilent Technologies
  • Applied Gene Technologies
  • Arca Biopharma
  • Beckman Coulter/Cepheid/Danaher
  • Becton Dickinson
  • Biokit
  • bioMerieux
  • Bio-Rad
  • Decode Genetics
  • Diasorin
  • 栄研化学(Eiken Chemical)
  • Elitech Group
  • Enzo Biochem
  • Exact Sciences
  • 富士レビオ(Fujirebio)
  • Grifols
  • Hologic/Gen-Probe
  • Illumina
  • LabCorp/Sequenom
  • Leica Biosystems/Kreatech
  • Li-Cor Biosciences
  • Myriad Genetics
  • Proteome Sciences
  • Qiagen
  • Quest Diagnostics
  • QuidelOrtho
  • Roche
  • 島津製作所(Shimadzu)
  • Siemens Healthineers
  • タカラバイオ(Takara Bio)
  • Tecan Group
  • Thermo Fisher

レポート詳細

図表

List of Tables
Major Companies Developing or Marketing AIDS Molecular
Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Adenovirus
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Bartonella
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Campylobacter
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Candida
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Chlamydia
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Clostridium
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Coronavirus
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Cryptosporidium
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing CMV Molecular
Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Echovirus Molecular
Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Enterovirus Molecular
Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing EBV Molecular
Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Giardia
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Gonorrhea
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Hantavirus
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Helicobacter
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Hepatitis
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Herpes
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Influenza
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Legionella
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Lyme
Disease Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Measles
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Meningitis
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Mononucleosis
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Mumps
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Mycoplasma
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Pneumonia
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing RSV
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Rotavirus
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Rubella
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Salmonella
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Septicemia
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Shigella
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Streptococci
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Syphilis
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Toxoplasmosis
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Trichomonas
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Tuberculosis
Molecular Diagnostic and Other Direct
Identification Tests
Oncogenes Potential Application in Cancer Diagnosis
Major Companies Developing or Marketing Cancer
Molecular Diagnostic Tests
Major Companies Developing or Marketing Molecular
Diagnostic Tests For Genetic Diseases
Germany
Molecular Diagnostics Test Volume And Sales
By Major Application
Germany
Laboratories Performing DNA Sequencing
By Market Segment
Germany
Molecular Diagnostics Market
Potential Laboratory Universe by Market Segment
Germany
Molecular Diagnostics Test Volume
By Major Application
Germany
Major Infectious Disease Test Volume by Assay
Germany
Major Infectious Disease Test Volume by Method
Germany
Molecular Diagnostics Market
By Major Application
Germany
Molecular Diagnostics Market
Estimated Sales And Market Shares of Major Suppliers
Germany
Major Infectious Disease Diagnostics Market by Assay
Germany
AIDS Testing Market
Estimated Sales by Major Supplier
Germany
CMV Testing Market
Estimated Sales by Major Supplier
Germany
EBV Testing Market
Estimated Sales by Major Supplier
Germany
Gonorrhea Testing Market
Estimated Sales by Major Supplier
Germany
Hepatitis Testing Market
Estimated Sales by Major Supplier
Germany
Hepatitis C Testing Market
Estimated Sales by Major Supplier
Germany
HIV/Hepatitis Blood Screening NAT Market
Reagent Sales by Major Supplier
Germany
Herpes Testing Market
Estimated Sales by Major Supplier
Germany
Influenza Testing Market
Estimated Sales by Major Supplier
Germany
Meningitis Testing Market
Estimated Sales by Major Supplier
Germany
Mycoplasma Testing Market
Estimated Sales by Major Supplier
Germany
Pneumonia Testing Market
Estimated Sales by Major Supplier
Germany
RSV Testing Market
Estimated Sales by Major Supplier
Germany
Rotavirus Testing Market
Estimated Sales by Major Supplier

この商品のレポートナンバー

0000043025

最近見たレポート

2017年版 スマートグリッド市場の実態と将来展望

− スマートグリッド市場実態予測・系統安定化・仮想発電所 −

スマートエネルギー 〜 Smart-grid編

2017/09/22

77,000 円(税込)

2018年版 住宅、低圧用エネルギーソリューションの流通と販売チャネル動向調査

2018/04/17

198,000 円(税込)

業務用ビデオコミュニケーションの導入・利用実態調査 2020

〜ビデオ会議、Web会議、Microsoft Teams、 Googleハングアウト、ZOOM等のビジネスアプリ(ビデオ通話)の導入状況・利用実態・使い分け〜

2019/11/20

198,000 円(税込)

2020年版 ホーム/パーソナル ヘルスケア 生体センシング・技術開発動向調査

−コロナ後の非接触・リモート・自動化技術と、人生100年時代に向けたセンサー・AI の利活用−

2020/06/01

132,000 円(税込)

リチウムイオン電池(LiB)リサイクル技術

~レアメタル回収・各種処理手法とリサイクルに貢献する研究開発動向

2025/04/24

59,400 円(税込)

特許情報分析(パテントマップ)から見た 表面プラズモン技術〔2025年版〕 技術開発実態分析調査報告書

2025/05/26

44,770 円(税込)

TOP